Abstract
This study’s goal was to assess the diagnostic value of the USPIO-(ultra-small superparamagnetic iron oxide) enhanced magnetic resonance imaging (MRI) in detection of vulnerable atherosclerotic plaques in abdominal aorta in experimental atherosclerosis. Thirty New Zealand rabbits were randomly divided into two groups, Group A and Group B. Each group comprised 15 animals which were fed with high cholesterol diet for 8 weeks and then subjected to balloon-induced endothelial injury of the abdominal aorta. After another 8 weeks, animals in Group B received adenovirus carrying p53 gene that was injected through a catheter into the aortic segments rich in plaques. Two weeks later, all rabbits were challenged with the injection of Chinese Russell’s viper venom and histamine. Pre-contrast images and USPIO-enhanced MRI images were obtained after pharmacological triggering with injection of USPIO for 5 days. Blood specimens were taken for biochemical and serological tests at 0 and 18 weeks. Abdominal aorta was histologically studied. The levels of serum ICAM-1 and VCAM-1 were quantified by ELISA. Vulnerable plaques appeared as a local hypo-intense signal on the USPIO-enhanced MRI, especially on T2*-weighted sequences. The signal strength of plaques reached the peak at 96 h. Lipid levels were significantly (p < 0.05) higher in both Group A and B compared with the levels before the high cholesterol diet. The ICAM-1 and VCAM-1 levels were significantly (p < 0.05) higher in Group B compared with Group A. The USPIO-enhanced MRI efficiently identifies vulnerable plaques due to accumulation of USPIO within macrophages in abdominal aorta plaques.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Atherosclerosis is a progressive pathophysiological phenomenon related to various cardiovascular diseases. Atherosclerotic plaques can be stable and unstable. The latter are also called vulnerable plaques since they easily rupture. Acute coronary syndrome (ACS) is typically caused by coronary atherosclerosis [1], and, specifically, by evolution of atherosclerotic plaque [2]. The pathophysiological mechanisms of atherosclerotic plaque rupture include vasospasm, plaque rupture, platelet adhesion, aggregation, and thrombus formation [3–5]. Vulnerable plaques have large lipid core, thin fibrous cap, intraplaque hemorrhage, and neo-vascularization of the vasa vasorum [6–9]. It is important to timely identity vulnerable plaques. To this end, several new techniques in molecular imaging were developed. Molecular imaging possesses high sensitivity, specificity, and signal-to-noise ratio [10]. High-resolution magnetic resonance imaging (MRI) is a non-invasive diagnostic method useful for plaque imaging [11, 12]. Recently, ultra-small superparamagnetic iron oxide (USPIO) was introduced as an MRI contrast agent. USPIO can be up-taken by macrophages which then become part of vulnerable plaques, facilitating accumulation of the agent in the shoulders or the necrotic lipid core of ruptured atherosclerotic plaques [13–15]. Thus, the USPIO-enhanced MRI may be useful for detection of macrophages within atherosclerotic plaques [16].
In this study, we assessed the feasibility of using the USPIO-enhanced MRI to detect macrophages and vulnerable plagues in experimental atherosclerosis.
Materials and Methods
Animal Model
Thirty male New Zealand white rabbits weighing 2.5–3.0 kg were obtained from Animal Center of Xuzhou Medical College. In all experimental studies, the Principles of Laboratory Animal Care [17] were followed. The experimental protocol was approved by the Animal Care Committee of Xuzhou Medical University.
Rabbits were randomly divided into two groups, Group A and B. The animals in both groups (n = 15 per group) were fed a high cholesterol diet (1 % cholesterol, 0.2 % bile salt, 10 % lard, 88.8 % normal diet; 150 g/kg/day) for 8 weeks and then subjected to balloon-induced endothelial injury of the abdominal aorta. All invasive procedures were performed under general anesthesia with an intravenous injection of 3 % sodium pentobarbital (30 mg/kg) via the rabbit ear vein. The endotheliocyte injury was performed from the aortic arch to the iliac bifurcation with a coronal artery sacculus tube of 4.0 Fr that was inserted at a length of 20 cm through the right femoral artery. This process was repeated three times, then the catheter was removed and incision closed.
At the end of 16 weeks, all rabbits of Group B received an injection of recombinant adenovirus carrying human wild-type p53 gene into their abdominal aorta plaques. Two weeks later, rabbits of both study groups were exposed to 0.15 mg/kg of Chinese Russell’s viper venom as a pharmacological stimulus (Guangdong Institute of Snake venom; Guangdong, China). The venom was injected intraperitoneally followed by injection of 0.02 mg/kg histamine (Shanghai Dongfeng Biological Technology, Shanghai, China) in the ear vein 30 min later.
MRI
Rabbits were anesthetized as above and imaged supine using 1.5T MRI system (PHILIPS, Gyroscan Intera 1.5T), synergy knee coil. The aorta USPIO-enhanced MRI imaging was conducted on all experimental rabbits at 0, 24, 48, 72, and 96 h after the medication (Chinese Russell’s viper venom and histamine). Sequential transverse images of the abdominal aorta were made from the renal arteries to the iliac bifurcation. The MR parameters were as follows. Image analysis: FSE (fast spin-echo) T1-weighted (repetition time TR = 470 ms, echo time TE = 5 ms, flip angle FA = 80°, slice thickness = 5 mm with no interval gap, matrix: 256 × 256), STIR (short time inversion recovery) T1-weighted (repetition time TR = 300 ms, echo time TE = 15 ms, slice thickness = 5 mm with no interval gap, matrix: 256 × 256). FSE T2-weighted (repetition time TR = 3000 ms, echo time TE = 85 ms, slice thickness = 5 mm with no interval gap, matrix: 256 × 256). FSE PDWI (repetition ime TR = 2500 ms, echo time TE = 11.5 ms, slice thickness = 5 mm with no interval gap, matrix: 256 × 256). FFE (fast field echo) T2-weighted (repetition time TR = 600 ms, echo time TE = 13.8 ms, FA = 30°, slice thickness = 5 mm with no interval gap, matrix: 192 × 256).
MRI Image Analysis
MR images were read independently by two cardiovascular specialists in separate reading sessions. Plaques were determined in different sequences as an increased signal intensity on T1-weighted images, and as a decreased signal intensity on T2-weighted and T2*-weighted images. The reading results from two specialists were compared. To decrease a bias in determining the plagues, two specialists reviewed the readings together during the third reading session. In addition, we calculated the number of lesions. A signal-to-noise ratio (SNR) was calculated as follows: SNR = SI/SD.
Biochemical Studies
Blood samples were collected for measurements of plasma total cholesterols (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C) at 0 and 18 weeks. In parallel, serum samples were obtained by centrifugation (10 min, 3000 rpm), and serum was used for measurements of ICAM-1 and VCAM-1 by respective ELISAs (Shanghai Huyu Biotechnology, Shanghai, China).
Histopathology and Immunohistochemistry
Abdominal aorta was excised and cut into two segments. One segment was placed into cold phosphate-buffered saline, trimmed of adherent connective tissue, and fixed in 4 % formaldehyde for 24 h. After that, first segment was embedded in paraffin and cut into 5-µm sections for staining with hematoxylin/eosin, or Perls and Masson stains. The second segment was fixed in 3 % glutaraldehyde for at least 2 h for subsequent electron microscopy.
Statistical Analysis
All statistical analyses were carried out using SPSS16.0 (SPSS, Chicago, USA). Quantitative variables are expressed as mean ± SD. Statistical comparisons were made using the t and one-way ANOVA tests. The data were considered statistically different at p < 0.05.
Results
Animal Model
Animal model was successfully established in 26 out 30 animals (14 animals in Group A and 12 animals in Group B). One animal in Group A died of anesthetic accident (respiratory distress due to an overdose of an anesthetic), while three animals in Group B died of medication overdose. Vulnerable plaques were observed in 12 animals (two animals of Group A and ten animals of Group B). Thirty-five atherosclerotic plaques and six vulnerable plaques were identified by pre-contrast and contrast-enhanced MRI after pharmacological triggering in Group A, while 29 vulnerable plaques were identified in Group B. Among the latter, 22 vulnerable plaques lesions occurred where wild-type p53 gene was adenovirally transduced. Plaque rupture and thrombosis occurred in nine lesions.
MR Imaging of Vulnerable Plaques
The formations of plaques were visible in both Group A and B. The stenosis of the abdominal aortic lumen was more prominent in Group B. Thus, the image of plaques in T1WI, PDWI, and T2*WI shows a slightly higher signal and an equal signal in T2WI (Fig. 1).
High resolution imaging using T1, T2 and proton density weighting allows for identification of the following substances: calcium (hypointense on all imaging sequences), lipids (T1- and PD-hyperintense, and T2-hypointense), and fibrous tissue (produces increased signal intensity on PD-weighted imaging, while isointense on T1 and isointense-to-hyperintense on T2-weighted imaging). These multi-contrast signal intensity “signatures” allow for characterization of various plaque components and plaque morphology on high-resolution imaging and, thereby, to assess plaque vulnerability (Fig. 2). The central signal of the plaques was significantly reduced after USPIO injection, especially in T2*WI (Fig. 3). The peak of negative reinforcement was reached 96 h after the injection (Table 1).
Biochemical Results
As expected, high cholesterol diet led to lipid disorders. Compared with levels before the study, blood lipids were significantly increased in both study groups at 18 weeks (Table 2). The levels of ICAM-1 and VCAM-1 were significantly higher in Group B (p < 0.05; Table 3).
Histopathological Analysis of Abdominal Aorta
We found an even wall thickening in Group A (Fig. 4a) while there was an obvious thickening with a substantial foam cell formation and large lipid core plaque hemorrhage in Group B (Fig. 4b). The Masson staining demonstrated collagen fiber hyperplasia in the vessel wall. A marked collagen fiber proliferation was seen in Group B (Fig. 4c). Further, Prussian blue staining in this group indicated iron deposition inside macrophages (Fig. 4d).
Discussion
Identification of atherosclerotic vulnerable plaques is in the focus of intensive research. In the current study, we tested a suitability of the USPIO-enhanced MRI to detect vulnerable plaques in an experimental model of atherosclerosis.
Most of the models for atherosclerotic vulnerable plaques are not reliable. High cholesterol diet only leads to establishment of stable plaques. To circumvent this, Russell viper venom and histamine were used to trigger vulnerable plaques [18]. Further, Cheng et al. [19] established an animal model of vulnerable plaques by overexpressing p53 gene in experimental plaque. p53 controls abnormal proliferation of smooth muscle cells and promotes apoptosis of vascular smooth muscle cells [20]. In the present study, we utilized both pharmacological induction and overexpression of p53 in local plaques to facilitate establishment of vulnerable plaques.
Of all non-invasive imaging techniques, MRI is shown to be superior in artery lumen imaging and detailed information about the artery wall. In addition, imaging techniques can quantify lumen plaque burden and plaque constituents [21]. We demonstrate here that USPIO-enhanced MRI is sensitive to detect inflamed plaques. Using MRI enhanced with Sinerem (type of USPIO), Trivedi et al. [22] reported that high-risk individuals with inflamed plaques may be identified on the basis of a “focal” area of signal loss visualized on MRI after Sinerem infusion. Vulnerable plaques contain large numbers of inflammatory cells, including macrophages. Therefore, number of macrophages can be an important marker of vulnerable plaques. In a recent study [23], it was confirmed that combination of SPIO-labeled endothelial cells and MRI can be used to detect atherosclerotic plaques. In particular, this approach may be more suitable for instable plaques and early plaques due to the presence of active macrophages in lesions [23]. Further, it was demonstrated that a susceptibility gradient mapping-MRI allows a sensitive detection and quantification of intraplaque iron oxide particles after injection of very small iron oxide particles [24].
USPIO is a new type of a magnetic MRI contrast agent which can be identified by reticuloendothelial system. Moreover, because of long plasma half-life of USPIO, it can accumulate in macrophages of reticuloendothelial system. When USPIO is absorbed by macrophages, superparamagnetic effect causes inhomogeneity of the local magnetic field. Then, different components of a plaque (fat, calcification, fibrous tissue and thrombosis) can be identified due to their specific unique characteristic MRI signals [25].
In our study, we found loss of signals in rabbits that had T2*-weighted spiral sequence with USPIO-enhanced MRI. This was mainly due to formation of fibrous plaque in a lipid core stage. Its center is the main component of cholesterol-containing solid crystalline or liquid crystal cholesterol ester. The signal of the cholesterol crystalline solid and liquid crystal cholesterol ester lipid was significantly reduced compared with normal lipid with T2*-weighted sequence. We found more plaque sections with signal decline. These changes were significant, and our results were comparable with those reported by Kooi et al. [26]. In a different study, it was reported that areas of signal intensity reduction that correspond to USPIO/macrophage-positive histological sections demonstrate a quantitative MR signal reduction [27]. Intravenously injected USPIO are up-taken by phagocytosis by plaque macrophages and are mainly deposited under the intima of foam cells, as was demonstrated by pathology [28]. Atherosclerosis is associated with foam cell fusion and necrotic material collapse. The shedding of endometrium and the rupture of a fibrous cap can be seen as deposition of blue-stained particles of iron after the USPIO injection. This contrast agent is mainly gathered in the macrophages that engulf a large amount of lipid deposited in the intima, causing changes in MRI signal. It was also shown that macrophages play an important role in the plaque lipid core formation, expansion, and a plaque rupture [29].
The degree of macrophage aggregation is an important indicator to determine stability and activity of atherosclerotic plaque. For up to 48 h after infusion, the imaging can identify macrophages in vivo. We further confirmed that USPIO have a long half-life in blood (30 h) that allows phagocytosis of the contrast agent by cells of the monocyte–macrophage system within the atheromatous plaque [27]. The T2*WI sequence of USPIO-enhanced plaque that shows a more sensitive negative reinforcement helps to estimate the number of macrophages in the plaque and gauge inflammation.
In conclusion, our results suggest that the USPIO-enhanced MRI combined with histopathological analysis is useful in detection of inflammatory tissues. The USPIO-enhanced MRI can identify vulnerable plaques by detecting USPIO in macrophages and show neovascularization within the plaque in the abdominal aorta. Further, this technique is superior to conventional contrast agents in the identification of different components within the plaque. In addition, it can also estimate inflammatory infiltration in plaque. Therefore, it can be used as a new technology in detection of vulnerable plaques [16].
Abbreviations
- USPIO:
-
Ultra-small superparamagnetic iron oxide
- MRI:
-
Magnetic resonance imaging
- T2*WI:
-
T2*-weighted imaging
- T1WI:
-
T1-weighted imaging
- T2WI:
-
T2-weighted imaging
- PDWI:
-
Proton density weighted imaging
- ICAM-1:
-
Intercellular adhesion molecule-1
- VCAM-1:
-
Vascular cell adhesion molecule-1
- ACS:
-
Acute coronary syndrome
- SNR:
-
Signal to noise ratio
- SI:
-
Signal interesting
- SD:
-
Standard deviation
- ANOVA:
-
Analysis of variance
- FSE:
-
Fast spin echo
- TR:
-
Repetition time
- TE:
-
Echo time
- FA:
-
Flip angle
- STIR:
-
Short time inversion recovery
- FFE:
-
Fast field echo
- TC:
-
Total cholesterols
- TG:
-
Triglycerides
- LDL-C:
-
Low density lipoprotein-cholesterol
- HDL-C:
-
High density lipoprotein-cholesterol
- ELISA:
-
Enzyme-linked immunosorbent assay
- SGM:
-
Susceptibility gradient mapping
- VSOP:
-
Very small iron oxide particle
References
Fishbein, M. C. (2010). The vulnerable and unstable atherosclerotic plaque. Cardiovascular Pathology, 2010(19), 6–11.
Mizuno, Y., Jacob, R. F., & Mason, R. P. (2011). Inflammation and the development of atherosclerosis. Journal of Atherosclerosis and Thrombosis, 18, 351–358.
Nguyen, C. M., & Levy, A. J. (2010). The mechanics of atherosclerotic plaque rupture by inclusion/matrix interfacial decohesion. Journal of Biomechanics, 2010(43), 2702–2708.
Bond, A. R., & Jackson, C. L. (2011). The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture. Journal of Biomedicine and Biotechnology, 2011(2011), 379069.
Guagliumi, G., Musumeci, G., Pierli, C., Fineschi, M., & Musuraca, A. C. (2010). Imaging of vulnerable plaque. Giornale Italiano Cardiologia (Rome), 11, 16s–21s.
Falk, E., Shah, P. K., & Fuster, V. (1995). Coronary plaque disruption. Circulation, 92, 657–671.
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., et al. (2003). From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation, 2003(108), 1664–1672.
Fleiner, M., Kummer, M., Mirlacher, M., Sauter, G., Cathomas, G., Krapf, R., & Biedermann, B. C. (2004). Arterial neovascularization and inflammation in vulnerable patients: Early and late signs of symptomatic atherosclerosis. Circulation, 110, 2843–2850.
Staub, D., Schinkel, A. F., Coll, B., Coli, S., van der Steen, A. F., Reed, J. D., et al. (2010). Contrast-enhanced ultrasound imaging of the vasa vasorum: From early atherosclerosis to the identification of unstable plaques. JACC Cardiovascular Imaging., 3, 761–771.
Skotland, T. (2012). Molecular imaging: Challenges of bringing imaging of intracellular targets into common clinical use. Contrast Media & Molecular Imaging, 7, 1–6.
Nemoto, S. (2011). Diagnostic imaging of carotid stenosis: Ultrasound, magnetic resonance imaging, and computed tomography angiography. Nihon Geka Gakkai Zasshi, 112, 371–376. In Japanese.
Gao, T., He, X., Yu, W., Zhang, Z., & Wang, Y. (2011). Atherosclerotic plaque pathohistology and classification with high-resolution MRI. Neurological Research, 33, 325–330.
Ross, R. (1999). Atherosclerosis—an inflammatory disease. New England Journal of Medicine, 340, 115–126.
Tang, T., Howarth, S. P., Miller, S. R., Trivedi, R., Graves, M. J., King-Im, J. U., et al. (2006). Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke, 37, 2266–2270.
Howarth, S. P., Tang, T. Y., Graves, M. J., U-King-Im, J. M., Li, Z. Y., Walsh, S. R., et al. (2007). Non-invasive MR imaging of inflammation in a patient with both asymptomatic carotid atheroma and an abdominal aortic aneurysm: a case report. Annals of Surgical Innovation and Research, 1, 4.
Metz, S., Beer, A. J., Settles, M., Pelisek, J., Botnar, R. M., Rummeny, E. J., & Heider, P. (2011). Characterization of carotid artery plaques with USPIO-enhanced MRI: Assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. International Journal of Cardiovascular Imaging, 27, 901–912.
Institutional Animal Care and Use Committee. (2011). Guide for the care and use of laboratory animals. Washington, D.C: The National Academies Press.
Constantinides, P., & Chakravarti, R. N. (1961). Rabbit arterial thrombosis production by systemic procedures. Archives of Pathology, 72, 197–208.
Chen, W. Q., Zhang, L., Liu, Y. F., Chen, L., Ji, X. P., Zhang, M., et al. (2007). Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers. American Journal of Physiology Heart and Circulatory Physiology, 293, H2836–H2844.
Yonemitsu, Y., Kaneda, Y., Tanaka, S., Nakashima, Y., Komori, K., Sugimachi, K., & Sueishi, K. (1998). Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circulation Research, 82, 147–156.
Saam, T., Hatsukami, T. S., Takaya, N., Chu, B., Underhill, H., Kerwin, W. S., et al. (2007). The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology, 244, 64–77.
Trivedi, R. A., Mallawarachi, C., U-King-Im, J. M., Graves, M. J., Horsley, J., Goddard, M. J., et al. (2006). Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1601–1606.
Zhou, Q., Yang, K. R., Gao, P., Chen, W. L., Yang, D. Y., Liang, M. J., & Zhu, L. (2011). An experimental study on MR imaging of atherosclerotic plaque with SPIO marked endothelial cells in a rabbit model. Journal of Magnetic Resonance Imaging, 34, 1325–1332.
Makowski, M. R., Varma, G., Wiethoff, A. J., Smith, A., Mattock, K., Jansen, C. H., et al. (2011). Noninvasive assessment of atherosclerotic plaque progression in ApoE−/− mice using susceptibility gradient mapping. Circulation Cardiovascular Imaging, 4, 295–303.
Clarke, S. E., Beletsky, V., Hammond, R. R., Hegele, R. A., & Rutt, B. K. (2006). Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke, 37, 93–97.
Kooi, M. E., Cappendijk, V. C., Cleutjens, K. B., Kessels, A. G., Kitslaar, P. J., Borgers, M., et al. (2003). Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation, 107, 2453–2458.
Trivedi, R. A., U-King-Im, J. M., Graves, M. J., Cross, J. J., Horsley, J., Goddard, M. J., et al. (2004). In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke, 35, 1631–1635.
Tabas, I., Williams, K. J., & Boren, J. (2007). Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation, 116, 1832–1844.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V., & Fallon, J. T. (1994). Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation, 90, 775–778.
Acknowledgments
This study was supported by the grants for postdoctoral studies (No. 53431002 and China Postdoctoral Science Foundation No. 2012M512177) and Xuzhou Scientific Technology Grant (Nos. XF11C103 and XM13B047).
Author information
Authors and Affiliations
Corresponding author
Additional information
Chun-mei Qi, Lili Du and Ji Hao have contributed equally to this work and should be consider co-first authors.
Rights and permissions
About this article
Cite this article
Qi, Cm., Du, L., Wu, Wh. et al. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI. Cell Biochem Biophys 73, 331–337 (2015). https://doi.org/10.1007/s12013-015-0591-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0591-y